174 related articles for article (PubMed ID: 28071625)
1. Thymic epithelial tumors: Can fluorodeoxyglucose positron emission tomography help in predicting histologic type and stage?
Purandare NC; Pramesh CS; Karimundackal G; Jiwnani S; Agrawal A; Shah S; Agarwal JP; Prabhash K; Noronha V; Joshi A; Kumar R; Rangarajan V
Indian J Cancer; 2016; 53(2):270-273. PubMed ID: 28071625
[TBL] [Abstract][Full Text] [Related]
2. ¹⁸F-fluorodeoxyglucose positron emission tomography for evaluation of thymic epithelial tumors: utility for World Health Organization classification and predicting recurrence-free survival.
Seki N; Sakamoto S; Karube Y; Oyaizu T; Ishihama H; Chida M
Ann Nucl Med; 2014 Apr; 28(3):257-62. PubMed ID: 24430867
[TBL] [Abstract][Full Text] [Related]
3. Fluorodeoxyglucose Positron Emission Tomography Can Provide Useful Information for Differentiating Thymic Epithelial Tumors.
Tomita M; Ayabe T; Tsuchiya K; Nakamura K
Thorac Cardiovasc Surg; 2018 Jun; 66(4):345-349. PubMed ID: 28728209
[TBL] [Abstract][Full Text] [Related]
4. The utility of [18F]-fluorodeoxyglucose positron emission tomography-computed tomography in thymic epithelial tumours.
Fukumoto K; Taniguchi T; Ishikawa Y; Kawaguchi K; Fukui T; Kato K; Matsuo K; Yokoi K
Eur J Cardiothorac Surg; 2012 Dec; 42(6):e152-6. PubMed ID: 23024234
[TBL] [Abstract][Full Text] [Related]
5. Utility of 18F-fluorodeoxyglucose positron emission tomography for distinguishing between the histological types of early stage thymic epithelial tumours.
Eguchi T; Yoshida K; Hamanaka K; Shiina T; Koizumi T; Kawakami S; Oguchi K; Amano J
Eur J Cardiothorac Surg; 2012 May; 41(5):1059-62. PubMed ID: 22219437
[TBL] [Abstract][Full Text] [Related]
6. Role of combined 18F-FDG-PET/CT for predicting the WHO malignancy grade of thymic epithelial tumors: a multicenter analysis.
Lococo F; Cesario A; Okami J; Cardillo G; Cavuto S; Tokunaga T; Apolone G; Margaritora S; Granone P
Lung Cancer; 2013 Nov; 82(2):245-51. PubMed ID: 23992878
[TBL] [Abstract][Full Text] [Related]
7. 18F-fluorodeoxyglucose positron emission tomography/computed tomography and the relationship between fluorodeoxyglucose uptake and the expression of hypoxia-inducible factor-1α, glucose transporter-1 and vascular endothelial growth factor in thymic epithelial tumours.
Toba H; Kondo K; Sadohara Y; Otsuka H; Morimoto M; Kajiura K; Nakagawa Y; Yoshida M; Kawakami Y; Takizawa H; Kenzaki K; Sakiyama S; Bando Y; Tangoku A
Eur J Cardiothorac Surg; 2013 Aug; 44(2):e105-12. PubMed ID: 23674658
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of fluorine-18 fluorodeoxyglucose-positron emission tomography in management strategy for thymic epithelial tumors.
Matsumoto I; Oda M; Takizawa M; Waseda R; Nakajima K; Kawano M; Mochizuki T; Ikeda H; Watanabe G
Ann Thorac Surg; 2013 Jan; 95(1):305-10. PubMed ID: 23200236
[TBL] [Abstract][Full Text] [Related]
9. Is (18)F-FDG PET useful in predicting the WHO grade of malignancy in thymic epithelial tumors? A meta-analysis.
Treglia G; Sadeghi R; Giovanella L; Cafarotti S; Filosso P; Lococo F
Lung Cancer; 2014 Oct; 86(1):5-13. PubMed ID: 25175317
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of [18F]fluoro-2-deoxy-D-glucose positron emission tomography for predicting the World Health Organization malignancy grade of thymic epithelial tumors.
Igai H; Matsuura N; Tarumi S; Chang SS; Misaki N; Go T; Ishikawa S; Yokomise H
Eur J Cardiothorac Surg; 2011 Jul; 40(1):143-5. PubMed ID: 20951602
[TBL] [Abstract][Full Text] [Related]
11. Is a positron emission tomography-computed tomography scan useful in the staging of thymic epithelial neoplasms?
Viti A; Terzi A; Bianchi A; Bertolaccini L
Interact Cardiovasc Thorac Surg; 2014 Jul; 19(1):129-34. PubMed ID: 24648467
[TBL] [Abstract][Full Text] [Related]
12. Superiority of [
Shen X; Zhou X; Yao Y; Meng X; Song Y; Yang Z; Li N
Eur J Nucl Med Mol Imaging; 2023 Sep; 50(11):3414-3424. PubMed ID: 37316675
[TBL] [Abstract][Full Text] [Related]
13. Value of 18F-FDG PET/CT for Predicting the World Health Organization Malignant Grade of Thymic Epithelial Tumors: Focused in Volume-Dependent Parameters.
Park SY; Cho A; Bae MK; Lee CY; Kim DJ; Chung KY
Clin Nucl Med; 2016 Jan; 41(1):15-20. PubMed ID: 26545017
[TBL] [Abstract][Full Text] [Related]
14. Combined imaging with 18F-FDG-PET/CT and 111In-labeled octreotide SPECT for evaluation of thymic epithelial tumors.
De Luca S; Fonti R; Palmieri G; Federico P; Del Prete G; Pacelli R; Pace L; De Placido S; Salvatore M; Del Vecchio S
Clin Nucl Med; 2013 May; 38(5):354-8. PubMed ID: 23486323
[TBL] [Abstract][Full Text] [Related]
15. 18F-FDG-PET/CT predicts grade of malignancy and invasive potential of thymic epithelial tumors.
Ito T; Suzuki H; Sakairi Y; Wada H; Nakajima T; Yoshino I
Gen Thorac Cardiovasc Surg; 2021 Feb; 69(2):274-281. PubMed ID: 32734427
[TBL] [Abstract][Full Text] [Related]
16. Value of 18F-FDG PET/computed tomography in predicting the simplified WHO grade of malignancy in thymic epithelial tumors.
Zhao J; Wang H; Li Q
Nucl Med Commun; 2020 Apr; 41(4):405-410. PubMed ID: 32032191
[TBL] [Abstract][Full Text] [Related]
17. Utility of 18FDG-PET for differentiating the grade of malignancy in thymic epithelial tumors.
Endo M; Nakagawa K; Ohde Y; Okumura T; Kondo H; Igawa S; Nakamura Y; Tsuya A; Murakami H; Takahashi T; Yamamoto N; Ito I; Kameya T
Lung Cancer; 2008 Sep; 61(3):350-5. PubMed ID: 18304691
[TBL] [Abstract][Full Text] [Related]
18. 18F-fluorodeoxyglucose and 11C-acetate positron emission tomography are useful modalities for diagnosing the histologic type of thymoma.
Shibata H; Nomori H; Uno K; Sakaguchi K; Nakashima R; Iyama K; Tomiyoshi K; Kaji M; Goya T; Suzuki T; Horio H
Cancer; 2009 Jun; 115(11):2531-8. PubMed ID: 19326456
[TBL] [Abstract][Full Text] [Related]
19. FDG PET-CT aids in the preoperative assessment of patients with newly diagnosed thymic epithelial malignancies.
Benveniste MF; Moran CA; Mawlawi O; Fox PS; Swisher SG; Munden RF; Marom EM
J Thorac Oncol; 2013 Apr; 8(4):502-10. PubMed ID: 23446204
[TBL] [Abstract][Full Text] [Related]
20. 18F-FDG PET/CT of thymic epithelial tumors: usefulness for distinguishing and staging tumor subgroups.
Sung YM; Lee KS; Kim BT; Choi JY; Shim YM; Yi CA
J Nucl Med; 2006 Oct; 47(10):1628-34. PubMed ID: 17015898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
